Alaunos Therapeutics (TCRT) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $921000.0.
- Alaunos Therapeutics' Total Current Liabilities rose 1150.12% to $921000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $921000.0, marking a year-over-year increase of 1150.12%. This contributed to the annual value of $692000.0 for FY2024, which is 6462.17% down from last year.
- As of Q3 2025, Alaunos Therapeutics' Total Current Liabilities stood at $921000.0, which was up 1150.12% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Alaunos Therapeutics' Total Current Liabilities ranged from a high of $32.9 million in Q3 2022 and a low of $692000.0 during Q4 2024
- In the last 5 years, Alaunos Therapeutics' Total Current Liabilities had a median value of $5.1 million in 2023 and averaged $11.4 million.
- As far as peak fluctuations go, Alaunos Therapeutics' Total Current Liabilities soared by 9697.64% in 2022, and later plummeted by 9273.28% in 2024.
- Quarter analysis of 5 years shows Alaunos Therapeutics' Total Current Liabilities stood at $16.0 million in 2021, then surged by 50.65% to $24.2 million in 2022, then plummeted by 91.91% to $2.0 million in 2023, then tumbled by 64.62% to $692000.0 in 2024, then soared by 33.09% to $921000.0 in 2025.
- Its Total Current Liabilities was $921000.0 in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.